with elevated clinic BP and ambulatory daytime BP Ն130/85 mm Hg were randomised double-blind to receive AML 5 mg (nϭ47) or LOS 50 mg (nϭ46). Doses were increased to AML 10 mg or LOS 100 mg and combined with hydrochlorothiazide and other antihypertensive agents excluding ACE inhibitors in order to reach target clinic BPϽ 130/85 mm Hg. Clinic and ambulatory BP, UAE and glomerular filtration rate (GFR) were assessed at baseline and at prespecified timepoints during the 3-year period.
P-441 EFFECT OF LERCANIDIPINE, FELODIPINE, AND NIFEDIPINE GITS ON BLOOD PRESSURE AND HEART RATE: LERCANIDIPINE IN ADULTS STUDY

Roberta Romito, Mariavittoria Pitalis, Paolo Rizzon, for the Lercanidipine in Adult (LEAD) Study Group. Section of Cardiovascular Diseases, University of Bari, Bari, Italy.
The aim of the Lercanidipine in Adults (LEAD) study was to compare the efficacy and tolerability of lercanidipine, felodipine, and nifedipine gastrointestinal therapeutic system (GITS) in adults (aged 31 to 74 years) with mild-to-moderate essential hypertension (SBP 140-180 mm Hg and DBP 95-109 mm Hg). A total of 325 patients were randomized in this multicenter, double-blind, parallel-group trial. After a 1-week washout period and a 2-week placebo run-in, patients received 1 of the following 8-week treatments: lercanidipine 10 mg/d (nϭ109), felodipine 10 mg/d (nϭ110), or nifedipine GITS 30 mg/d (nϭ106). After 4 weeks of treatment, the dosage was doubled in nonresponders (DBP Ն95 mm Hg and DBP reduction Ͻ10 mm Hg from baseline). Heart rate (HR) was measured via electrocardiogram tracings at rest and under stress (mental stress and isometric stress). At 8 weeks, significant reductions in BP were observed in all 3 groups (PϽ0.01). Increases in HR induced by stressful conditions before and after treatment were not exacerbated during active treatment in all 3 groups. Lercanidipine and nifedipine GITS were better tolerated than felodipine. In particular, the incidence of edema with lercanidipine was 5.5% versus 6.6% with nifedipine GITS and 13% with felodipine. The incidence of discontinuations due to any adverse event was 4.6% in the lercanidipine group, 9.4% in the nifedipine GITS group, and 15.5% in the felodipine group (PϽ0.05). These results demonstrate that although the 3 dihydropyridine calcium antagonists significantly and equally decreased SBP and DBP, lercanidipine exhibited a superior tolerability profile. Information to the patients and their relatives about the project; written informations to family physicians.
Volunteers with a nurse's help will phone the patients periodically on the base of their situations and needs; during the telephone call they administer a questionnaire with items about patients' illness and all necessary informations.
Later a specialist will analyse the questionnaires and will decide if the patient needs hospitalization or a new telephone call or nothing at all. . From these patients 18 (67%) had no hospitalization during one year; 1 (NYHA III) died for stroke; 8 (30%) had hospitalization.
Among the patients that had hospitalization 3 (NYHA class I) bacause of ischaemic cardiopathy (1 PTCA, 1 AMI), or COPD (1 p.); 3 (NYHA class II) because of diabetes and pacing (1), gastroenteric haemorrage (1), stroke (1); 2 (NYHA class III) because of TIA and neuropathy (1) or in Day Hospital for worsening of HF (1).
Conclusions: Our experience shows that a good integration between In-Hospital and Out-Hospital assistance is the best management of HF and the role of integration is growing as an important non pharmacological therapy.
Key Words: Heart Failure, non pharmacological therapy, in and out hospital assistance
P-443 MEDICATION COMPLIANCE AND EFFECTS OF COGNITIVE -BEHAVIORAL INTERVENTION IN WOMEN WITH TREATED HYPERTENSION
Margaret Scisney-Matlock, Susan P. Steigerwalt. School of Nursing, University of Michigan, Ann Arbor, MI; Hypertension and Nephrophy, St. John Hospital and Medical Center, Detroit, MI. Research using electronic monitoring of medication taking patterns is emerging as the "gold standard" for assessing medication compliance. The purpose was to examine patterns of medication-taking after a cognitive-behavioral intervention (CBI) comprised of a 30-day home based program involving reading tailored messages and or home blood pressures only. The CBI was designed to structure knowledge or cognitive representations of medication-taking behavior and to improve sense of 197A AJH-May 2003-VOL. 16, NO. 5, PART 
